期刊文献+

吉西他宾中间体的合成新工艺 被引量:2

SYNTHESIS OF INTERMEDIATES FOR GEMCITABINE
下载PDF
导出
摘要 从D0甘露醇出发,经NaIO。氧化、Reformasty反应、脱去异丙叉基保护基团、自身成环合成了吉西他宾关键中间体3,5-双-O-苯甲酰基-2-脱氧-2,2-二氟-1-氧代-D-呋喃核糖。对二氟五元核糖糖环结构中二氟的引入和3-位羟基手性的控制关键反应条件进行了优化。结果表明,将未活化的锌粉加入三烷基氯硅烷、未经重结晶的2,3-O-异丙亚基-》甘油醛直接参与反应,反应温度45℃,顺反产物的选择性提高到1:13,关键中间体3R,3S-2,2-二氟-3-羟基-3-(2,2-二甲基-1,3-二氧戊环-4-基)戊酸乙酯的合成时间从4d缩短到3~12h,目标产物质量总收率76.4%。产物结构经IR与1HNMR确证。 Starting from D-mannital, the key intermediate of gemcitabine, 3, 5-di-O-benzoyl-2-deoxy-2 and 2-difluoro-l-oxo-ribofuranose, was synthesized through sodium periodate oxidation, Reformasty reaction, separating the protective moieties of iso-propyl-benzyliden and cyclization. The introduction of difluoro in the saccharide ring of difluoro-pentahydric-ribose and the control of 3-hydroxyl chirality were optimized. Under the following optimized conditions, i. e. , directly adding inactive zinc powder into trialkyl-phosphine-chlorosilane, using un-reerystallized G2 and reaction temperature 45 ℃, the selectivity of cis-trans products was increased to 1 : 13 and the time required for the synthesis of G3 was shortened from 4 d to 3 -12 h, with the total yield reaching to 76.4%. The structure of the product was characterized by IR and 1H NMR.
出处 《精细石油化工》 CAS CSCD 北大核心 2009年第3期1-4,共4页 Speciality Petrochemicals
基金 河南省教育厅自然科学研究资助计划项目(2009C150004)
关键词 吉西他宾 3 5-双-O-苯甲酰基-2-脱氧-2 2-二氟-1-氧代D-呋喃核糖 D-甘露醇 合成 gemcitabine 3,5-di-O-benzoyl-2-deoxy-2,2-difluoro-l-oxo-ribofuranose D-mannital synthesize
  • 相关文献

参考文献9

二级参考文献47

  • 1姚娟,徐媺,刘淑娟,谢清红,阎磊.吉西他滨加卡铂治疗晚期非小细胞肺癌[J].中国癌症杂志,2004,14(4):371-372. 被引量:6
  • 2曾子君,李伟雄,陈应瑞.紫杉醇同期放疗化疗与PF方案诱导化疗加局部放疗治疗晚期鼻咽癌近期疗效比较[J].实用肿瘤杂志,2004,19(6):472-474. 被引量:7
  • 3王树森,管忠震.鼻咽癌化学治疗研究现状与展望[J].肿瘤防治杂志,2004,11(4):422-424. 被引量:13
  • 4Fandi A,Altun M,Azli N,et al.Nasopharyngeal cancer,epidemiology,staging and treatment [J].Semin Oncol,1994,21(2) :382.
  • 5Zhang EP,Liang PG,Cai KL,et al.Radiation therapy of nasopharyngeal carcinoma:Prognostic factors based on a 10-year follow-up of 1302 patients[J].Int J Radiat Oncol Biol Phys,1989,16(2):301.
  • 6Isobe K,Ito H,Shigematsu N,et al.Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy:distant metastasis and local recurrence[J].Int J Oncol,1998,12 (5):1183.
  • 7Ma BB,Chan AT.Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma[J].Cancer,2005,103 (1):22.
  • 8Al-Kourainy K,Crissman J,Ensley J,et al.Excellent response to cisplatin based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma [J].Am J Clin Oncol,1988,11 (3):427.
  • 9Foo KF,Tan EH,Leong SS,et al.Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type[J].Ann Oncol,2002,13(1):150.
  • 10Chua DT,Sham JS,Au GK.A phase Ⅱ study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy[J].Oral Oncol,2003,39(4):361.

共引文献29

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部